Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-029920

SrVP/CFO/Prin Fin & Acct Ofcr acquired 3,365 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2025-03-27 Grant or award +3,365 22,733 D
Derivatives
Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr 2025-03-27 Grant or award · Stock Options (Right to Buy) +13,460 13,460 D
Loading xslF345X05/tm2510809-2_4seq1.xml…